Back

Efficacy and safety of P2Y12 inhibitors plus aspirin versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: a meta-analysis of randomized controlled trials

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New findings in stroke Acute Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Iosif Karalis

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Cardiac autonomic changes after stroke
Doctor M. Schreinlechner (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Apolipoprotein C3-rich low-density lipoprotein (AC3RL) exacerbates cerebral ischaemic stroke injury by increasing BBB leakage via LOX-1
Miss P. Tsai (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Machine learning identification of risk factors for ischaemic stroke in patients with heart failure with reduced ejection fraction but without atrial fibrillation: A report from WARCEF trial
Doctor B. Huang (Chongqing, CN)
Abstract Slides Video
Presentation thumbnail
Imaging signs of carotid plaque vulnerability predict subclinical neurological events in asymptomatic patients: the carotid artery multi-modality imaging prognostic study
Doctor L. Gargani (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Oral anticoagulants or antiplatelets for cryptogenic stroke: a systematic review and meta-analysis
Doctor P. Lee (Bronx, US)
Abstract Slides Video

Access the full session

Session thumbnail
New findings in stroke

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis
thumbnail
Congress Presentation
A shorter duration of dual-antiplatelet therapy for percutaneous coronary intervention following acute coronary syndrome: a meta-analysis of randomized clinical trials
thumbnail
Congress Presentation
PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources